Heidi Cuthbert

Clinical-stage biopharmaceutical firm Traws Pharma (NASDAQ:TRAW) updated guidance for its influenza prophylaxis program to enable a planned Phase 2a trial.

Outdoor Holding Company (NASDAQ:POWW) reported a 10.1% increase in fourth-quarter revenue to $13.9 million.

Fervo Energy (NASDAQ:FRVO) reported a first-quarter net loss of $31.8 million while funding multiple utility-scale geothermal facilities.

Ennis (NYSE:EBF) reported a 1.4% increase in first-quarter revenue to $98.6 million for the period ended May 31, 2026.

The Bank of England has revised its proposed framework for systemic sterling stablecoins, scrapping individual holding limits in favour of an aggregate issuance cap per systemic issuer.

British Prime Minister Keir Starmer resigned outside Downing Street as the British Pound fell below $1.32.

Humanity Protocol (CRYPTO:H) declined 10.41% over the past 24 hours to US$0.1962, reducing its market capitalisation to approximately US$55.75 million as sellers continued to dominate trading.

Recce Pharmaceuticals (ASX:RCE) received ethical approval to advance its Australian diabetic foot infection trial to a 200-patient Phase 3 study.

XRP (CRYPTO:XRP) briefly broke below the closely watched US$1.14 support level on Sunday before buyers stepped in, driving the token from a low near US$1.12 back toward US$1.15.

Mineral Resources (ASX:MIN) announced an updated executive succession plan following a leadership assessment by recruitment firm Korn Ferry.